Clover Health Investments, Corp.

CLOV Healthcare Healthcare Plans

Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024. In the quarter to June 2026, revenue grew 55.6%, EPS grew 350.0% and free cash flow grew 406.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

4.48 0.20 −4.27%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
292×
Dividend yield
—
F-score
3/9
Altman Z
0.44
Beneish M
−1.72
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 4 3 4

+8 more TTM periods

ROE
(5.10%) (16.86%) (26.33%) (17.08%)
ROA
(2.84%) (8.89%) (15.25%) (9.62%)
ROIC
(8.62%) (26.18%) (28.37%) (26.10%)
Return on Tangible Assets
(10.84%) (48.12%) (81.15%) (40.80%)
Average Days of Receivables
10.78 12.13 17.99 11.92
Free Cash Flow per Share
0.14 0.10 (0.13) (0.17)
Free Cash Flow
74.21 54.54 (68.98) (86.38)
Other line items

Show all line items

Columns are period end dates